Rockefeller Capital Management L.P. Raises Stock Holdings in GE HealthCare Technologies Inc. $GEHC

Rockefeller Capital Management L.P. raised its stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 235.1% during the 4th quarter, Holdings Channel.com reports. The fund owned 111,243 shares of the company’s stock after purchasing an additional 78,043 shares during the quarter. Rockefeller Capital Management L.P.’s holdings in GE HealthCare Technologies were worth $9,124,000 as of its most recent filing with the SEC.

Other institutional investors have also recently made changes to their positions in the company. Laurel Wealth Advisors LLC purchased a new position in shares of GE HealthCare Technologies during the fourth quarter valued at approximately $26,000. Optima Capital LLC bought a new stake in GE HealthCare Technologies in the 4th quarter worth approximately $27,000. Godfrey Financial Associates Inc. bought a new stake in GE HealthCare Technologies in the 4th quarter worth approximately $27,000. Montag A & Associates Inc. raised its stake in GE HealthCare Technologies by 105.4% during the 4th quarter. Montag A & Associates Inc. now owns 341 shares of the company’s stock valued at $28,000 after buying an additional 175 shares during the last quarter. Finally, Transamerica Financial Advisors LLC lifted its holdings in shares of GE HealthCare Technologies by 331.6% during the 4th quarter. Transamerica Financial Advisors LLC now owns 341 shares of the company’s stock valued at $28,000 after buying an additional 262 shares during the period. Hedge funds and other institutional investors own 82.06% of the company’s stock.

GE HealthCare Technologies Trading Up 0.1%

Shares of GE HealthCare Technologies stock opened at $64.94 on Friday. GE HealthCare Technologies Inc. has a 1-year low of $58.75 and a 1-year high of $89.77. The company’s fifty day simple moving average is $64.67 and its 200-day simple moving average is $74.01. The company has a debt-to-equity ratio of 0.95, a current ratio of 1.22 and a quick ratio of 0.95. The stock has a market capitalization of $29.54 billion, a PE ratio of 15.54, a P/E/G ratio of 1.77 and a beta of 0.74.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings data on Wednesday, April 29th. The company reported $0.99 EPS for the quarter, missing the consensus estimate of $1.07 by ($0.08). GE HealthCare Technologies had a return on equity of 20.46% and a net margin of 9.10%.The company had revenue of $5.13 billion during the quarter, compared to analysts’ expectations of $5.04 billion. During the same quarter last year, the company earned $1.01 earnings per share. The company’s revenue for the quarter was up 7.4% on a year-over-year basis. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. As a group, equities analysts anticipate that GE HealthCare Technologies Inc. will post 4.89 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently issued reports on the company. Royal Bank Of Canada initiated coverage on GE HealthCare Technologies in a research note on Tuesday. They issued an “outperform” rating and a $80.00 price target on the stock. Wall Street Zen downgraded GE HealthCare Technologies from a “buy” rating to a “hold” rating in a report on Saturday, March 21st. JPMorgan Chase & Co. dropped their target price on GE HealthCare Technologies from $80.00 to $65.00 and set a “neutral” rating on the stock in a research report on Thursday, April 30th. BTIG Research cut their price target on GE HealthCare Technologies from $85.00 to $80.00 and set a “buy” rating for the company in a research note on Wednesday, April 29th. Finally, Argus reduced their price target on shares of GE HealthCare Technologies from $95.00 to $80.00 and set a “buy” rating for the company in a research report on Tuesday, May 19th. Ten equities research analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $80.20.

Insiders Place Their Bets

In related news, Director Watkin Phoebe L. Yang acquired 1,000 shares of the business’s stock in a transaction that occurred on Friday, May 8th. The stock was bought at an average cost of $63.01 per share, for a total transaction of $63,010.00. Following the purchase, the director owned 13,702 shares in the company, valued at $863,363.02. The trade was a 7.87% increase in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, Director Rodney F. Hochman bought 1,618 shares of GE HealthCare Technologies stock in a transaction that occurred on Tuesday, May 12th. The stock was purchased at an average cost of $62.03 per share, with a total value of $100,364.54. Following the completion of the acquisition, the director directly owned 1,618 shares in the company, valued at $100,364.54. This represents a ∞ increase in their position. The SEC filing for this purchase provides additional information. Over the last 90 days, insiders have bought 21,847 shares of company stock valued at $1,361,355. 0.36% of the stock is currently owned by corporate insiders.

GE HealthCare Technologies Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.